Profound Medical Corp (PROF-Q) Analyst Research & Price Targets - The Globe and Mail

Earnings Estimates

	Current Qtr03/2026	Next Qtr06/2026	Fiscal Yr12/2026	Fiscal Yr12/2027
Average Estimate	$-0.24	$-0.25	$-0.97	$-0.81
Number of Estimates	3	3	3	3
High Estimate	$-0.23	$-0.22	$-0.79	$-0.27
Low Estimate	$-0.25	$-0.29	$-1.24	$-1.62
Prior Year	$-0.36	$-0.52	$-1.41	$-0.97
Growth Rate Est. (year over year)	+33.33%	+51.92%	+31.21%	+16.49%

Earnings History - Surprises*

	Qtr Ending12/2025	Qtr Ending09/2025	Qtr Ending06/2025	Qtr Ending03/2025
Reported	$-0.27	$-0.26	$-0.52	$-0.36
Estimate	$-0.27	$-0.38	$-0.43	$-0.29
Difference	unch	+0.12	-0.09	-0.07
Surprise	unch	+31.58%	-20.93%	-24.14%

* Earnings are based on GAAP income from continuing operations.

Average Analyst Ratings

4.40

3 Mths Ago5

4.40

2 Mths Ago5

4.40

1 Mth Ago5

4.40

Current5

Ratings Values:

Strong Buy5

Moderate Buy4

Hold3

Moderate Sell2

Strong Sell1

Ratings Breakdown

	3 Mths Ago	2 Mths Ago	1 Mth Ago	Current
# of Analysts:	5	5	5	5
	3 1	3 1	3 1	3 1
Holds	1	1	1	1

Key:

Strong Buy

Moderate Buy

Hold

Moderate Sell

Strong Sell

More from The Globe

The most oversold and overbought stocks on the TSX

Lululemon appoints long-time Nike executive Heidi O’Neill as new CEO

Bullish on Pembina Pipeline Corp.

How investors should digest the stock market’s ‘sugar high’

Market Factors: Top picks, sector review for income-heavy utilities sector

The most oversold and overbought stocks on the TSX

The highest-yielding stocks on the TSX, plus risk data

Barlow’s Research Roundup: These stocks are biggest winners from oil price volatility